Cell Cryopreservation Market Set for High Growth Amid Pharma & Biotech Demand
![]() |
Cell Cryopreservation Market |
Cell cryopreservation involves
freezing cells at extremely low temperatures (-80°C or below) to preserve them
for long periods of time. The process allows cells to be stored and thawed as
needed for applications like maintaining cell/tissue cultures, stem cell
therapeutic developments, and biobanking. It offers numerous advantages
compared to the traditional approach of short-term storage at 4°C. The
technique allows indefinite storage of cells and tissues without deteriorating
viability and functionality. This provides flexibility to researchers and
industries to retrieve biological samples as per requirement.
The global cell cryopreservation market is estimated to be valued at US$ 263.58 billion in 2024 and is
expected to exhibit a CAGR of 5.7% over the forecast period of 2024 to
2031.
The increasing adoption in the
pharmaceutical and biotechnology industries is a major factor driving market
growth. Manufacturers in these industries widely rely on cell and tissue Cell
Cryopreservation Market Size
techniques to preserve biological products for quality check, research, and
development purposes. Besides industrial usage, rising application in stem cell
therapeutics, regenerative medicine, and organ transplantations is also
propelling demand.
Key Takeaways
Key players operating in the cell cryopreservation market are BASF, DSM, Kemin
Industries, Naturex, Synthite Industries, Aarkay Food Products, Dohler,
Sensient Technologies, Vitablend. These players are adopting strategies like
partnerships, collaborations, and new product launches to sustain competition.
The global market presents ample opportunities for players in the form of
untapped regions. Emerging economies in Asia Pacific and Latin America with
growing stem cell research and regenerative medicine sectors are lucrative for
investments. North America and Europe currently dominate the market but are
anticipated to witness relatively slower growth compared to developing regions.
Globally, companies are expanding their production and R&D facilities
across multiple regions. They are also entering into long-term supply contracts
and collaborations with end-user industries and academic institutions to ensure
a strong global footprint. Partnerships with local players help gain
familiarity with regional market dynamics and regulations.
Market Drivers
Growing stem cell research and clinical trials: Increasing government funding
and initiatives to develop stem cell therapeutics are driving the use of cell
cryopreservation techniques in academic and clinical research. Many therapies
in clinical trials rely on cryopreserved stem cells.
Rising biopharma outsourcing: Pharmaceutical manufacturers are outsourcing more
production processes including cell banking to contract service providers. This
is increasing the commercial demand for scalable cryopreservation equipment and
consumables.
Market Restrain
High costs associated:
Cryopreservation equipment, media, and protocols require substantial
investments. The overall process adds to product costs. This can restrain
widespread adoption, especially in price-sensitive developing markets.
Challenges in optimizing protocols: Variations exist across cell types in terms
of optimal cooling and warming rates, cryoprotectants, and handling.
Standardizing protocols needs extensive research which slows market evolution.
Segment
Analysis
The global cell cryopreservation
market is segmented based on type, technology, application, and end-user.
Within type, stem cells is expected to be the dominant sub-segment during the
forecast period owing to rising stem cell research activities and growing
prevalence of cancer and genetic disorders. The technology segment is divided
into slow freezing, vitrification, and controlled rate freezing. The
vitrification technology sub-segment holds a significant share in the market
and is expected to maintain its dominance through the forecast period. This is
attributed to vitrification's low maintenance cost and ability to eliminate ice
crystal formation, thereby preventing cell damage.
Global Analysis
The Asia Pacific region is
anticipated to witness the fastest growth in the cell cryopreservation market
during the forecast period. This growth is attributed to factors such as rising
research funding for stem cell research, increasing investment from market
players, and growing awareness related to stem cell and tissue preservation in
emerging countries of the region such as China, India, and South Korea. North
America dominated the global market in 2024 and is expected to continue its
stronghold during the forecast period. This dominance is owing to
well-developed healthcare infrastructure, rising research in regenerative
medicine and tissue engineering, and growing biobanking activities in the
region.
Gets
More Insights on, Cell
Cryopreservation Market
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market
research industry. She specializes in writing well-researched articles from
different industries, including food and beverages, information and technology,
healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
Comments
Post a Comment